Use of concurrent G-CSF + GM-CSF vs G-CSF alone for mobilization of peripheral blood stem cells in children with malignant disease
- 1 August 2000
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 26 (4), 365-369
- https://doi.org/10.1038/sj.bmt.1702523
Abstract
There is limited experience in the mobilization of peripheral blood progenitor cells (PBPC) in children and the optimal method for PBPC mobilization is unknown. The present study was conducted to ascertain whether mobilization with G-CSF + GM-CSF (group I) provides some advantage over G-CSF alone (group II) in terms of collected CD34+ cells and hematopoietic recovery following myeloablative conditioning in children with malignancies. An economic analysis was also performed. Each group comprised 21 consecutive patients. The mean number of aphereses was 1.5 ± 0.5 in group I and 1.2 ± 0.46 in group II (NS). The mean number of CD34+ cells was 3.8 × 106 ± 4.03/kg in group I and 4.2 ± 5.4 in group II (NS). The mean number of total blood volumes (TBV) processed was 4.4 ± 1.5 in group I and 4.3 ± 1.5 in group II (NS). The mean duration of the procedure was 276 ± 74.1 min in group I and 286.7 ± 75.9 min in group II (NS), and the inlet flow was 45.1 ± 12 ml/min in group I and 39.5 ± 15.1 ml/min in group II (NS). No significant differences in the neutrophil and platelet engraftment probability were observed between the two groups. The mean overall cost of group II was not statistically significant from that of group I (US$ 9521 ± 330 vs US$ 10201 ± 1028, P = NS). The cost of mobilization was significantly higher in group I than in group II, conditioning regimen costs were similar in both groups and the costs related to the post-transplant period were similar in both groups. We conclude that PBPC mobilization with G-CSF + GM-CSF in children does not enhance hematological recovery in comparison with mobilization using G-CSF alone. However, the combination of G-CSF + GM-CSF does not significantly increase the overall cost of transplantation. Bone Marrow Transplantation (2000) 26, 365–369.Keywords
This publication has 14 references indexed in Scilit:
- Randomized Trial of Filgrastim, Sargramostim, or Sequential Sargramostim and Filgrastim After Myelosuppressive Chemotherapy for the Harvesting of Peripheral-Blood Stem CellsJournal of Clinical Oncology, 2000
- Analysis of Engraftment Kinetics in Pediatric Patients Undergoing Autologous PBPC TransplantationJournal of Hematotherapy, 1998
- Peripheral Blood Progenitor Cell Collection by Large-Volume Leukapheresis in Low-Weight ChildrenJournal of Hematotherapy, 1998
- COLLECTION AND TRANSPLANTATION OF PERIPHERAL BLOOD PROGENITOR CELLS MOBILIzED BY G‐CSF ALONE IN CHILDREN WITH MALIGNANCIESBritish Journal of Haematology, 1996
- Autologous Transplantation with Peripheral Blood Stem Cells in Children and Young Adults After Myeloablative Treatment: Nonrandomized Comparison Between GM-CSF and G-CSF for MobilizationJournal of Hematotherapy, 1995
- Use of G‐CSF alone to mobilize peripheral blood stem cells for collection from childrenBritish Journal of Haematology, 1994
- Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG‐CSF): an analysis of factors correlating with the tempo of engraftment after transplantationBritish Journal of Haematology, 1994
- Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factorBlood, 1993
- Large-scale collection of circulating haematopoietic progenitors in cancer patients treated with high-dose cyclophosphamide and recombinant human GM-CSFEuropean Journal of Cancer and Clinical Oncology, 1990
- CLINICAL COLLECTION AND USE OF PERIPHERAL BLOOD STEM CELLS IN PEDIATRIC PATIENTSTransplantation, 1989